{"words": ["quantify", "effect", "genetic", "factors", "generations", "influencing", "age", "onset", "aao", "families", "frontotemporal", "lobar", "dementia", "ftd", "due", "c9orf72", "hexanucleotide", "repeat", "expansions", "grn", "studied", "504", "affected", "individuals", "133", "families", "c9orf72", "repeat", "expansions", "90", "ftd", "families", "mutations", "grn", "2", "major", "genes", "responsible", "ftd", "amyotrophic", "lateral", "sclerosis", "intrafamilial", "correlations", "aao", "analyzed", "variance", "component", "methods", "used", "heritability", "estimates", "generational", "effects", "hazard", "rates", "aao", "assessed", "using", "cox", "proportional", "hazard", "generational", "effect", "influencing", "aao", "detected", "c9orf72", "grn", "families", "nevertheless", "estimated", "proportion", "aao", "variance", "explained", "genetic", "factors", "high", "ftd", "caused", "c9orf72", "repeat", "expansions", "44", "p", "62", "aao", "dementia", "specifically", "taken", "account", "p", "lesser", "degree", "grn", "families", "26", "p", "intrafamilial", "correlation", "analyses", "revealed", "significant", "level", "correlations", "c9orf72", "families", "according", "degree", "kinship", "pattern", "intrafamilial", "correlations", "also", "suggested", "potential", "modifiers", "acting", "aao", "nonsignificant", "correlation", "values", "observed", "grn", "results", "provide", "original", "evidence", "genetic", "modifiers", "strongly", "influence", "aao", "c9orf72", "carriers", "effects", "seem", "weaker", "grn", "families", "constitutes", "rational", "search", "genetic", "biomarkers", "could", "help", "improve", "genetic", "counseling", "patient", "care", "monitoring", "therapeutic", "trials"], "authors": [["Barbier", "Mathieu", "M", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Camuzat", "Agn\u00e8s", "A", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Houot", "Marion", "M", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Clot", "Fabienne", "F", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Caroppo", "Paola", "P", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Fournier", "Cl\u00e9mence", "C", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Rinaldi", "Daisy", "D", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Pasquier", "Florence", "F", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Hannequin", "Didier", "D", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Pariente", "J\u00e9r\u00e9mie", "J", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Larcher", "Kathy", "K", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], [null, null, null, null], [null, null, null, null], ["Brice", "Alexis", "A", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["G\u00e9nin", "Emmanuelle", "E", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Sabbagh", "Audrey", "A", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."], ["Le Ber", "Isabelle", "I", "INSERM U1127 (M.B., A.C., P.C., C.F., D.R., A.B., I.L.B.), CNRS UMR 7225, UPMC Universit\u00e9 Paris 06 UMR S1127, Sorbonne Universit\u00e9 Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, ICM; Ecole Pratique des Hautes Etudes-EPHE (A.C.), PSL Research University; Institute of Memory and Alzheimer's Disease (IM2A) (M.H., P.C., D.R., I.L.B.), Centre of Excellence of Neurodegenerative Disease (CoEN), ICM, APHP Department of Neurology, Hopital Piti\u00e9-Salp\u00eatri\u00e8re, University Paris 6; Unit\u00e9 Fonctionnelle de Neurog\u00e9n\u00e9tique Mol\u00e9culaire et Cellulaire (F.C., K.L.), D\u00e9partement de G\u00e9n\u00e9tique et Cytog\u00e9n\u00e9tique, AP-HP, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Paris, France; Carlo Besta Neurological Institute (P.C.), IRCCS Foundation, Milano, Italy; Assistance Publique-H\u00f4pitaux de Paris (D.R., I.L.B.), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Centre de r\u00e9f\u00e9rence D\u00e9mences Rares, Paris, France; Universit\u00e9 de Lille (F.P.), Inserm U1171, CHU Lille, Labex DistAlz, LiCEND, France; Department of Neurology (D.H.), University Hospital, Rouen, France; D\u00e9partement de Neurologie (J.P.), CHU Toulouse, Equipe TONIC, INSERM, Place du Dr Baylac, France; INSERM (E.G.), UMR1078, CHU Brest, Universit\u00e9 Bretagne Occidentale, France; and Institut de Recherche pour le D\u00e9veloppement (IRD) (A.S.), UMR216-MERIT, Paris, France."]], "title": "Factors influencing the age at onset in familial frontotemporal lobar dementia: Important weight of genetics.", "year": null, "sentences": ["To quantify the effect of genetic factors and generations influencing the age at onset (AAO) in families with frontotemporal lobar dementia (FTD) due to C9ORF72 hexanucleotide repeat expansions and GRN mutations.We studied 504 affected individuals from 133 families with C9ORF72 repeat expansions and 90 FTD families with mutations in GRN, 2 major genes responsible for FTD and/or amyotrophic lateral sclerosis.", "Intrafamilial correlations of AAO were analyzed, and variance component methods were used for heritability estimates.", "Generational effects on hazard rates for AAO were assessed using mixed-effects Cox proportional hazard models.A generational effect influencing AAO was detected in both C9ORF72 and GRN families.", "Nevertheless, the estimated proportion of AAO variance explained by genetic factors was high in FTD caused by C9ORF72 repeat expansions (44%; p = 1.10e-4), 62% when the AAO of dementia was specifically taken into account (p = 8.10e-5), and to a lesser degree in GRN families (26%; p = 0.17).", "Intrafamilial correlation analyses revealed a significant level of correlations in C9ORF72 families according to the degree of kinship.", "A pattern of intrafamilial correlations also suggested potential X-linked modifiers acting on AAO.", "Nonsignificant correlation values were observed in GRN families.Our results provide original evidence that genetic modifiers strongly influence the AAO in C9ORF72 carriers, while their effects seem to be weaker in GRN families.", "This constitutes a rational to search for genetic biomarkers, which could help to improve genetic counseling, patient care, and monitoring of therapeutic trials."], "id": "29264395", "text": "To quantify the effect of genetic factors and generations influencing the age at onset (AAO) in families with frontotemporal lobar dementia (FTD) due to C9ORF72 hexanucleotide repeat expansions and GRN mutations.We studied 504 affected individuals from 133 families with C9ORF72 repeat expansions and 90 FTD families with mutations in GRN, 2 major genes responsible for FTD and/or amyotrophic lateral sclerosis. Intrafamilial correlations of AAO were analyzed, and variance component methods were used for heritability estimates. Generational effects on hazard rates for AAO were assessed using mixed-effects Cox proportional hazard models.A generational effect influencing AAO was detected in both C9ORF72 and GRN families. Nevertheless, the estimated proportion of AAO variance explained by genetic factors was high in FTD caused by C9ORF72 repeat expansions (44%; p = 1.10e-4), 62% when the AAO of dementia was specifically taken into account (p = 8.10e-5), and to a lesser degree in GRN families (26%; p = 0.17). Intrafamilial correlation analyses revealed a significant level of correlations in C9ORF72 families according to the degree of kinship. A pattern of intrafamilial correlations also suggested potential X-linked modifiers acting on AAO. Nonsignificant correlation values were observed in GRN families.Our results provide original evidence that genetic modifiers strongly influence the AAO in C9ORF72 carriers, while their effects seem to be weaker in GRN families. This constitutes a rational to search for genetic biomarkers, which could help to improve genetic counseling, patient care, and monitoring of therapeutic trials.", "doi": "10.1212/NXG.0000000000000203", "journal": ["Neurology. Genetics", "Neurol Genet"], "date": "2018-01-18_23:42:22"}